Sarepta (SRPT) director gets 16,875 RSUs vesting after one year

Rhea-AI Filing Summary

Mayo Stephen reported acquisition or exercise transactions in this Form 4 filing.

Sarepta Therapeutics director Stephen Mayo received an equity grant in the form of restricted stock units. He was awarded 16,875 RSUs of common stock at no purchase price. Each RSU represents one share of common stock.

The RSUs will vest on the earlier of the one-year anniversary of the grant date and the next annual meeting of stockholders that occurs at least 50 weeks after the prior year’s annual meeting. Following this award, Mayo directly holds 18,640 shares of Sarepta common stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Mayo Stephen

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	16,875	$0.00	--

Holdings After Transaction: Common Stock — 18,640 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

RSUs granted: 16,875 units Grant price per share: $0.0000 per share Shares owned after grant: 18,640 shares +1 more

4 metrics

RSUs granted 16,875 units Restricted stock units awarded to Stephen Mayo

Grant price per share $0.0000 per share Equity compensation award, no purchase price

Shares owned after grant 18,640 shares Total common shares directly held by Stephen Mayo after transaction

Vesting schedule Earlier of one-year anniversary or next annual meeting (≥50 weeks after prior) Conditions for RSU vesting

Key Terms

restricted stock units ("RSUs"), annual meeting of stockholders, vest

3 terms

restricted stock units ("RSUs") financial

"The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

annual meeting of stockholders financial

"will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders"

vest financial

"The RSUs will vest on earlier of the one-year anniversary of the date of grant"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mayo Stephen

(Last) (First) (Middle)

215 FIRST STREET

SUITE 415

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sarepta Therapeutics, Inc. [ SRPT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/04/2026		A		16,875	A	(1)	18,640	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. The RSUs will vest on earlier of the one-year anniversary of the date of grant and the next annual meeting of stockholders which is at least 50 weeks after the immediately preceding year's annual meeting.

	/s/ Cristin L. Rothfuss, as Attorney-in-Fact for Stephen Mayo	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Sarepta Therapeutics (SRPT) report for Stephen Mayo?

Sarepta reported that director Stephen Mayo received a grant of 16,875 restricted stock units. Each RSU represents one share of common stock, awarded at no purchase price, increasing his direct holdings to 18,640 shares after the transaction.

How many Sarepta (SRPT) shares does Stephen Mayo hold after this Form 4?

After the RSU grant, Stephen Mayo directly holds 18,640 Sarepta common shares. This total reflects the newly awarded 16,875 restricted stock units, which convert to common stock as they vest under the disclosed vesting schedule.

What are the vesting terms of Stephen Mayo’s 16,875 RSUs at Sarepta (SRPT)?

The 16,875 RSUs vest on the earlier of the one-year anniversary of the grant date and Sarepta’s next annual stockholder meeting that occurs at least 50 weeks after the prior year’s annual meeting, aligning vesting with the company’s governance calendar.

Did Stephen Mayo buy or sell Sarepta (SRPT) stock in this Form 4?

The filing shows an acquisition through a grant of 16,875 restricted stock units, not an open-market purchase or sale. The grant was awarded at a price of $0.0000 per share as part of equity compensation, increasing his direct share position.

What type of equity did Sarepta (SRPT) grant to director Stephen Mayo?

Sarepta granted Stephen Mayo restricted stock units, or RSUs, tied to its common stock. Each RSU represents the right to receive one share of common stock, subject to the specified vesting schedule connected to the grant anniversary or the next qualifying annual meeting.